Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

Research Training Awards

Program Academic Research
RFA Status Open
Description

Supports applications for integrated institutional research training programs to support promising individuals who seek specialized training in the area of cancer research. Successful applicant institutions are expected to provide trainees with broad access to research opportunities across disciplinary lines and to maintain high standards for intellectual rigor and creativity.

Award: Up to $800,000 per year in total costs; Maximum duration: 5 years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release January 31, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Individual Investigator Research Awards

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.

Award: Up to $300,000 per year in total costs. Exceptions permitted if extremely well justified; maximum duration: 3 years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release January 23, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Individual Investigator Research Awards for Cancer in Children and Adolescents

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.

Award: Up to $300,000 per year in total costs. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release January 23, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Individual Investigator Research Awards for Clinical Translation

Program Academic Research
RFA Status Open
Description

Supports applications which propose innovative clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial or involve analyses of biospecimens from patients enrolled on a completed trial for which the outcomes are known. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices.

Award: Up to $400,000 per year in total costs. Maximum duration: 3 years. Applicants that plan on conducting a clinical trial as part of the project may request up to $600,000 in total costs and a maximum duration of 4 years. Exceptions permitted if extremely well justified.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release January 23, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Individual Investigator Research Awards for Computational Systems Biology of Cancer

Program Academic Research
RFA Status Open
Description

Supports applications for innovative mathematical and/or computational research projects addressing questions that will advance current knowledge in the (a) mechanisms that tie altered gene expression and downstream molecular mechanisms to functional cancer phenotypes and/or (b) mechanisms that tie tumor morphology to functional cancer phenotypes, and/or (c) mechanisms that tie treatment sequence and combination to evolving functional cancer phenotypes (that emerge as a result of treatment selection). Broadly speaking, functional cancer phenotypes include migratory, proliferative, metabolic and resistant cancer cell phenotypes.

Partnering of mathematical or computational scientists with cancer biologists or oncologists is highly recommended to form a truly interdisciplinary team that can both develop and validate models leading to a deeper integrated understanding of cancer progression and treatment.

Award: Up to $400,000 per year in total costs. Exceptions permitted if extremely well justified; maximum duration: 3 years.

Review Cycle Fiscal Year 2020 - Cycle 1
RFA Release January 23, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Individual Investigator Research Awards for Prevention and Early Detection

Program Academic Research
RFA Status Open
Description

Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, early-stage progression, and/or early detection of cancer. Research may be laboratory-, clinical-, or population- based, and may include behavioral/intervention, dissemination or health services/outcomes research to reduce cancer incidence or promote early detection. Competitive renewal applications accepted.

Award: Up to of $300,000 per year in total costs for up to 3 years for laboratory and clinical research; Up to $500,000 per year in total costs for 4 years for population-based research, including implementation research designed to accelerate the adoption and deployment of sustainable, evidence-based cancer prevention and screening interventions at multiple levels and in different clinical and community settings. Exceptions permitted if extremely well justified; maximum duration: 3 years for laboratory and clinical research and 4 years for population-based research.

Review Cycle Fiscal Year 2021 - Cycle 1
RFA Release January 23, 2020
Application Receipt March 04, 2020 - June 03, 2020
Application Review June 2020 - February 2021
Award Notification February 2021

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2020 - Cycle 1
RFA Release June 21, 2019
Application Receipt June 21, 2019 - June 20, 2020
Application Review Continuous
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million up to a period of five years.

Review Cycle Fiscal Year 2020 - Cycle 1
RFA Release June 21, 2019
Application Receipt June 21, 2019 - June 20, 2020
Application Review Continuous
Award Notification Continuous

Recruitment of Rising Stars

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding early-stage investigators to Texas, who have demonstrated the promise for continued and enhanced contributions to the field of cancer research.

Award: Up to $4 million over a period of five years.

Review Cycle Fiscal Year 2020 - Cycle 1
RFA Release June 21, 2019
Application Receipt June 21, 2019 - June 20, 2020
Application Review Continuous
Award Notification Continuous

Dissemination of CPRIT-Funded Cancer Control Interventions

Instructions for Applicants
Revised: 12/03/2019

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be in a position to develop one or more “products” based on the results of the CPRIT-funded intervention. The proposed project should also identify and assist others to prepare to implement the intervention and/or prepare for grant funding.

Award: Maximum of $300,000; Maximum duration of 24 months

Review Cycle Fiscal Year 2020 - Cycle 1
RFA Release June 06, 2019
Application Receipt June 06, 2019 - June 05, 2020
Application Review Continuous
Award Notification Continuous
Apply Now Grants Process

Sign Up for Our Newsletter